federal_register: 2021-26699
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-26699 | Real-World Data: Assessing Electronic Health Records and Medical Claims Data To Support Regulatory Decision-Making for Drug and Biological Products; Draft Guidance for Industry; Reopening of the Comment Period | Notice | The Food and Drug Administration (FDA or the Agency) is reopening the comment period for the document entitled "Real-World Data: Assessing Electronic Health Records and Medical Claims Data to Support Regulatory Decision-Making for Drug and Biological Products; Draft Guidance of Industry," published in the Federal Register on September 30, 2021. The Agency is taking this action to allow interested persons additional time to submit comments. | 2021-12-10 | 2021 | 12 | https://www.federalregister.gov/documents/2021/12/10/2021-26699/real-world-data-assessing-electronic-health-records-and-medical-claims-data-to-support-regulatory | https://www.govinfo.gov/content/pkg/FR-2021-12-10/pdf/2021-26699.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA or the Agency) is reopening the comment period for the document entitled "Real-World Data: Assessing Electronic Health Records and Medical Claims Data to Support Regulatory Decision-Making for Drug and Biological... |